These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. Outcomes of paclitaxel-eluting stent implantation in patients with stenosis of the left anterior descending coronary artery. Dangas G; Ellis SG; Shlofmitz R; Katz S; Fish D; Martin S; Mehran R; Russell ME; Stone GW; J Am Coll Cardiol; 2005 Apr; 45(8):1186-92. PubMed ID: 15837247 [TBL] [Abstract][Full Text] [Related]
5. [Sirolimus-eluting vs paclitaxel-eluting stents -- the trials confirm differences in clinical outcome]. Gil RJ Kardiol Pol; 2005 Nov; 63(5):574-6; discussion 577. PubMed ID: 16362868 [No Abstract] [Full Text] [Related]
6. Paclitaxel balloon coating, a novel method for prevention and therapy of restenosis. Scheller B; Speck U; Abramjuk C; Bernhardt U; Böhm M; Nickenig G Circulation; 2004 Aug; 110(7):810-4. PubMed ID: 15302790 [TBL] [Abstract][Full Text] [Related]
7. Engineering aspects of stents design and their translation into clinical practice. Sangiorgi G; Melzi G; Agostoni P; Cola C; Clementi F; Romitelli P; Virmani R; Colombo A Ann Ist Super Sanita; 2007; 43(1):89-100. PubMed ID: 17536159 [TBL] [Abstract][Full Text] [Related]
8. Coronary in-stent restenosis in diabetic patients after implantation of sirolimus or paclitaxel drug-eluting coronary stents. Kitoga M; Pasquet A; Preumont V; Kefer J; Hermans MP; Vanoverschelde JL; Buysschaert M Diabetes Metab; 2008 Feb; 34(1):62-7. PubMed ID: 18069029 [TBL] [Abstract][Full Text] [Related]
9. Review of the TAXUS Liberté SR paclitaxel-eluting coronary stent. Ahmed WH Expert Rev Med Devices; 2007 Mar; 4(2):117-20. PubMed ID: 17359218 [TBL] [Abstract][Full Text] [Related]
12. Predictive factors of restenosis after coronary implantation of sirolimus- or paclitaxel-eluting stents. Kastrati A; Dibra A; Mehilli J; Mayer S; Pinieck S; Pache J; Dirschinger J; Schömig A Circulation; 2006 May; 113(19):2293-300. PubMed ID: 16682614 [TBL] [Abstract][Full Text] [Related]
13. Images in cardiovascular medicine. Implantation of a drug-eluting stent for the coronary artery stenosis of Takayasu arteritis: de novo and in-stent restenosis. Kang WC; Han SH; Oh KJ; Ahn TH; Shin EK Circulation; 2006 May; 113(17):e735-7. PubMed ID: 16651477 [No Abstract] [Full Text] [Related]
14. Multiple predictors of coronary restenosis after drug-eluting stent implantation in patients with diabetes. Hong SJ; Kim MH; Ahn TH; Ahn YK; Bae JH; Shim WJ; Ro YM; Lim DS Heart; 2006 Aug; 92(8):1119-24. PubMed ID: 16449516 [TBL] [Abstract][Full Text] [Related]
15. Paclitaxel-eluting balloon: from bench to bed. De Labriolle A; Pakala R; Bonello L; Lemesle G; Scheinowitz M; Waksman R Catheter Cardiovasc Interv; 2009 Apr; 73(5):643-52. PubMed ID: 19309715 [TBL] [Abstract][Full Text] [Related]
16. Patterns of restenosis after drug-eluting stent implantation: Insights from a contemporary and comparative analysis of sirolimus- and paclitaxel-eluting stents. Corbett SJ; Cosgrave J; Melzi G; Babic R; Biondi-Zoccai GG; Godino C; Morici N; Airoldi F; Michev I; Montorfano M; Sangiorgi GM; Bonizzoni E; Colombo A Eur Heart J; 2006 Oct; 27(19):2330-7. PubMed ID: 16952923 [TBL] [Abstract][Full Text] [Related]
18. The paclitaxel-eluting stent in percutaneous coronary intervention: part I: background and clinical comparison to bare metal stents. Gruchalla KJ; Nawarskas JJ Cardiol Rev; 2006; 14(2):88-98. PubMed ID: 16493246 [TBL] [Abstract][Full Text] [Related]
19. Sirolimus-eluting stent showed better one-year outcomes than paclitaxel-eluting stent in a real life setting of coronary intervention in Koreans. Suh JW; Park JS; Cho HJ; Kim MS; Kang HJ; Cho YS; Koo BK; Chung WY; Youn TJ; Chae IH; Choi DJ; Kim HS; Sohn DW; Oh BH; Park YB Int J Cardiol; 2007 Apr; 117(1):31-6. PubMed ID: 17292498 [TBL] [Abstract][Full Text] [Related]
20. Understanding the drug-eluting stent trials. Coolong A; Kuntz RE Am J Cardiol; 2007 Sep; 100(5A):17K-24K. PubMed ID: 17719349 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]